ea0056s6.1 | Precision Medicine for diabetes (Endorsed by the European Journal of Endocrinology) | ECE2018
Florez Jose
In recent years technological and analytical advances have led to an explosion in the discovery of genetic loci associated with type 2 diabetes. However, their ability to improve prediction of disease outcomes beyond standard clinical risk factors has been limited. On the other hand, genetic effects on drug response may be stronger than those commonly seen for disease incidence. Pharmacogenetic findings may help to uncover new drug targets, illuminate pathophysiology, clarify ...